FdaApplication
NDA 205718
Identifiers
- fda_app_no: NDA205718
Properties
| Property | Value |
|---|---|
| applicant_name | HELSINN HEALTHCARE SA |
| application_type | NDA |
| approval_date | 2014-10-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AKYNZEO | NETUPITANT; PALONOSETRON HYDROCHLORIDE | 300MG;EQ 0.5MG BASE | CAPSULE;ORAL |
1 product